High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them

OncoImmunology

Volumn 1, Issue 9, 2012, Pages 1643-1644

  Wilde, Susanne ^a   Schendel, Dolores J ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Adoptive T cell therapy; Human cytotoxic CD8+ T lymphocytes; Melanoma; T cell receptor; TCR gene therapy; Th1 Th2 polycytokines

Indexed keywords

GAMMA INTERFERON; HLA A2 ANTIGEN; INTERLEUKIN 2; PROTEIN P53; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ALLOTYPE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; LYMPHOCYTE CLONE; MELANOMA; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 84884610820     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21717     Document Type: Note

References (10)

1. Uttenthal BJ, Chua I, Morris EC, Stauss HJ. Challenges in T cell receptor gene therapy. J Gene Med 2012; 14:386-99
2. June CH. Adoptive T cell therapy for cancer in the clinic. J Clin Invest 2007; 117:1466-76
3. De Visser KE, Schumacher TN, Kruisbeek AM. CD8+ T cell tolerance and cancer immunotherapy. J Immunother 2003; 26:1-11.
4. Schumacher TN. T-cell-receptor gene therapy. Nat Rev Immunol 2002; 2:512-9
5. Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 2009; 114:535-46
6. Offringa R. Antigen choice in adoptive T-cell therapy of cancer. Curr Opin Immunol 2009; 21:190-9
7. Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, Moris A, et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 2009; 113:6351-60.
8. Dutoit V, Rubio-Godoy V, Doucey MA, Batard P, Liénard D, Rimoldi D, et al. Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR. J Immunol 2002; 168:1167-71
9. Wilde S, Sommermeyer D, Leisegang M, Frankenberger B, Mosetter B, Uckert W, et al. Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition. J Immunol 2012; 189:598-605.
10. La Gruta NL, Turner SJ, Doherty PC. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity. J Immunol 2004; 172:5553-60.